000 -LEADER |
fixed length control field |
a |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220210095133.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220210b xxu||||| |||| 00| 0 eng d |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
AIKTC-KRRC |
Transcribing agency |
AIKTC-KRRC |
100 ## - MAIN ENTRY--PERSONAL NAME |
9 (RLIN) |
16011 |
Author |
Arun, K. |
245 ## - TITLE STATEMENT |
Title |
Evaluation of antidiabetic activity of zanthoxylum ovalifolium leaf extracts |
250 ## - EDITION STATEMENT |
Volume, Issue number |
Vol.13(2) |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
M P |
Name of publisher, distributor, etc. |
Innovare Academic Sciences Pvt Ltd |
Year |
2021 |
300 ## - PHYSICAL DESCRIPTION |
Pagination |
56-60p. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Objective:The present study was aimed to investigate the antidiabetic activity of ethanolic and aqueous extract of Zanthoxylum ovalifoliumon alloxan induced diabetic rat model in rats.Methods: The leaves of Zanthoxylum ovalifoliumwere evaluated for antidiabetic activity by using alloxan induced diabetic model in diabetic rats. Diabetes was induced by single intraperitoneal injection of alloxan (100 mg/kg) and rats were treated orally with test extracts, standard drug (glibenclamide 5 mg/kg) and vehicle for 21 d. The hypoglycemic effects and lipid profile of diabetic rats were assessed using diagnostic kits. Finally, histopathological studies were carried out for pancreas.Results: The acute toxicity studies revealed at the dose of 2000 mg/kg (b. w) of Zanthoxylum ovalifolium for ethanol and aqueous extract were found to be safe. A significant reduction (p<0.001) in blood glucose was observed in diabetic rats treated with different doses of extracts compared to untreated diabetic rats. The drug possesses a good hyperlipidemic effect by normalizing the lipid parameters. This was evidenced by histopathological studies; both glibenclamide and 400 mg/kg of Ethanolic extract does appear to be regulated diabetes at the cellular level, resulting in the restoration of near normal architecture pancreatic islet of langerhans.Conclusion:It can be concluded from our research findings that ethanolic and aqueous extract of Zanthoxylum ovalifoliumat high dose (400 mg/kg) exhibited significant antihyperglycemic activity than extract at low dose (200 mg/kg) in alloxan induced diabetic rats. These extracts also showed improvement in parameters like lipid profile as well as regeneration β-cells in the pancreas and so might be of value in diabetes treatment. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
9 (RLIN) |
4639 |
Topical term or geographic name entry element |
PHARMACEUTICS |
700 ## - ADDED ENTRY--PERSONAL NAME |
9 (RLIN) |
16012 |
Co-Author |
Virupaksha, J. H. |
773 0# - HOST ITEM ENTRY |
Place, publisher, and date of publication |
Bhopal Innovare Academic Sciences Pvt Ltd |
Title |
International journal of pharmacy and pharmaceutical science |
International Standard Serial Number |
2656-0097 |
856 ## - ELECTRONIC LOCATION AND ACCESS |
URL |
https://innovareacademics.in/journals/index.php/ijpps/article/view/37636/24297 |
Link text |
Click here |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Koha item type |
Articles Abstract Database |